D-Ribitol, 5-S-(3-amino-3-carboxypropyl)-1-C-(7-amino-1H-pyrazolo(4,3- d)pyrimidin-3-yl)-1,4-anhydro-5-thio-, (1S,5(S))-

Modify Date: 2025-08-25 13:09:09

D-Ribitol, 5-S-(3-amino-3-carboxypropyl)-1-C-(7-amino-1H-pyrazolo(4,3- d)pyrimidin-3-yl)-1,4-anhydro-5-thio-, (1S,5(S))- Structure
D-Ribitol, 5-S-(3-amino-3-carboxypropyl)-1-C-(7-amino-1H-pyrazolo(4,3- d)pyrimidin-3-yl)-1,4-anhydro-5-thio-, (1S,5(S))- structure
Common Name D-Ribitol, 5-S-(3-amino-3-carboxypropyl)-1-C-(7-amino-1H-pyrazolo(4,3- d)pyrimidin-3-yl)-1,4-anhydro-5-thio-, (1S,5(S))-
CAS Number 75899-14-8 Molecular Weight 384.41100
Density N/A Boiling Point N/A
Molecular Formula C14H20N6O5S Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name (2S)-2-Amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dih ydroxytetrahydro-2-furanyl]methyl}sulfanyl)butanoic acid (non-pre ferred name)
Synonym More Synonyms

 Chemical & Physical Properties

Molecular Formula C14H20N6O5S
Molecular Weight 384.41100
Exact Mass 384.12200
PSA 207.93000

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VJ0850000
CHEMICAL NAME :
D-Ribitol, 5-S-(3-amino-3-carboxypropyl)-1-C-(7-amino-1H-pyrazol o(4,3-d)pyrimidin-3-y l)-1,4- anhydro-5-thio-, (1S,5(S))-
CAS REGISTRY NUMBER :
75899-14-8
LAST UPDATED :
199612
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C14-H20-N6-O5-S
MOLECULAR WEIGHT :
384.46

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JKXXAF Japanese Kokai Tokyo Koho Patents. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #93-32550

 Synonyms

SF-837 A1,YL-704 B1,Espinomycin A2
Momicin
Myoxam
medemycin
S-Formycinyl-L-homocysteine
Macropen
YL 704B1
MoMicine
sf837
Aboren
Midecin
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.